Literature DB >> 4170754

Bacterial precipitins in serum of patients with cystic fibrosis.

M W Burns, J R May.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4170754     DOI: 10.1016/s0140-6736(68)90121-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  31 in total

1.  Serum precipitins against respiratory tract pathogens in 522 "normal" children, and 48 cases of cystic fibrosis treated with cloxacillin.

Authors:  D Lawson; J Porter
Journal:  Arch Dis Child       Date:  1976-11       Impact factor: 3.791

Review 2.  Cystic fibrosis. Infection and immunity to Staphylococcus aureus and Haemophilus influenzae.

Authors:  D P Greenberg; H R Stutman
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

3.  Chemoprophylaxis of respiratory infections.

Authors:  J Batten
Journal:  Postgrad Med J       Date:  1976-09       Impact factor: 2.401

4.  Bacterial infection in cystic fibrosis.

Authors:  J R May; N C Herrick; D Thompson
Journal:  Arch Dis Child       Date:  1972-12       Impact factor: 3.791

5.  Significance of Pseudomonas aeruginosa in sputum.

Authors:  M W Burns
Journal:  Br Med J       Date:  1973-08-18

6.  Agglutinin response to bacterial infection in acute exacerbations of chronic bronchitis.

Authors:  A C Nicholls; P E Pease; I D Green
Journal:  J Clin Pathol       Date:  1975-04       Impact factor: 3.411

Review 7.  Cystic fibrosis. Infection and immunity to Pseudomonas.

Authors:  R U Sorensen; R L Waller; J D Klinger
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

Review 8.  Alginate synthesis by Pseudomonas aeruginosa: a key pathogenic factor in chronic pulmonary infections of cystic fibrosis patients.

Authors:  T B May; D Shinabarger; R Maharaj; J Kato; L Chu; J D DeVault; S Roychoudhury; N A Zielinski; A Berry; R K Rothmel
Journal:  Clin Microbiol Rev       Date:  1991-04       Impact factor: 26.132

9.  Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis.

Authors:  G Döring; N Høiby
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

Review 10.  Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.

Authors:  J R Govan; V Deretic
Journal:  Microbiol Rev       Date:  1996-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.